NASDAQ
Nektar Therapeutics (NKTR) has a fcf yield of -29.26% as of Friday, May 29, 2026. This represents a 67.78% increase compared to its 12-month average of -90.81%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.